AGIOS PHARMACEUTICALS INC (AGIO) Stock Earnings & Estimates
USA - NASDAQ:AGIO - US00847X1046 - Common Stock
40 USD
-0.13 (-0.32%)
40 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.24M | 26.823M 88.36% | 36.498M 36.07% | 45.83M 25.57% | 116.06M 153.24% | 281.27M 142.35% | 568.3M 102.05% | 952.5M 67.61% | 1.333B 39.95% | 1.24B -6.98% | 1.507B 21.53% | |
| EBITDA YoY % growth | -380.48M -3.06% | -384.864M -1.15% | -420.084M -9.15% | -496.41M -18.17% | -493.338M 0.62% | -332.756M 32.55% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -389.04M -2.81% | -391.487M -0.63% | -425.737M -8.75% | -499.635M -17.36% | -499.666M -0.01% | -374.861M 24.98% | -406.258M -8.38% | -244.246M 39.88% | 103.27M 142.28% | 460.29M 345.72% | 678.67M 47.44% | |
| Operating Margin | -2,732.02% | -1,459.52% | -1,166.47% | -1,090.19% | -430.52% | -133.27% | -71.49% | -25.64% | 7.75% | 37.12% | 45.03% | |
| EPS YoY % growth | -4.24 -119.09% | -6.34 -49.53% | -7.00 -10.35% | -7.43 -6.20% | -7.34 1.25% | -5.78 21.23% | -4.72 18.40% | -1.59 66.19% | 1.86 216.63% | 5.44 192.60% | 8.18 50.23% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.99 -38.48% | -1.92 -24.16% | -2.00 -3.85% | -1.46 18.06% | -1.38 30.95% |
| Revenue Q2Q % growth | 12.506M 16.55% | 16.567M 89.86% | 14.226M 14.22% | 67.952M 427.58% | 114.89M 818.68% |
| EBITDA Q2Q % growth | -128.116M -7.31% | -124.239M -17.93% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -129.642M -3.68% | -131.5M -23.32% | -147.028M -15.72% | -72.054M 38.35% | -31.906M 75.39% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.78 26.32% | -1.94 | 0.16 | 8.09% |
| Q2 2025 Q2Q % growth | -1.93 -14.20% | -1.84 | -0.09 | -4.68% |
| Q1 2025 Q2Q % growth | -1.55 -6.90% | -1.82 | 0.27 | 14.81% |
| Q4 2024 Q2Q % growth | -1.44 16.28% | -1.72 | 0.28 | 16.46% |
| Q3 2024 Q2Q % growth | -2.42 -47.32% | 1.13 | -3.54 | -314.16% |
| Q2 2024 Q2Q % growth | -1.69 -11.92% | -1.63 | -0.06 | -3.39% |
| Q1 2024 Q2Q % growth | -1.45 1.36% | -1.68 | 0.23 | 13.79% |
| Q4 2023 Q2Q % growth | -1.72 -356.72% | -1.68 | -0.04 | -2.34% |
| Q3 2023 Q2Q % growth | -1.64 -10.07% | -1.74 | 0.10 | 5.56% |
| Q2 2023 Q2Q % growth | -1.51 10.12% | -1.59 | 0.08 | 5.17% |
| Q1 2023 Q2Q % growth | -1.47 15.52% | -1.74 | 0.27 | 15.28% |
| Q4 2022 Q2Q % growth | 0.67 138.51% | -1.65 | 2.32 | 140.64% |
| Q3 2022 Q2Q % growth | -1.49 4.49% | -1.80 | 0.31 | 17.18% |
| Q2 2022 Q2Q % growth | -1.68 -16.67% | -1.78 | 0.10 | 5.68% |
| Q1 2022 Q2Q % growth | -1.74 -106.46% | -1.85 | 0.11 | 5.81% |
| Q4 2021 Q2Q % growth | -1.74 -23.40% | -1.72 | -0.02 | -1.16% |
| Q3 2021 Q2Q % growth | -1.56 -9.09% | -1.62 | 0.06 | 3.75% |
| Q2 2021 Q2Q % growth | -1.44 -9.92% | -1.42 | -0.02 | -1.30% |
| Q1 2021 Q2Q % growth | 26.95 4,667.80% | -1.34 | 28.29 | 2,104.00% |
| Q4 2020 Q2Q % growth | -1.41 11.88% | -1.36 | -0.05 | -3.60% |
| Q3 2020 Q2Q % growth | -1.43 20.99% | -1.41 | -0.02 | -1.71% |
| Q2 2020 Q2Q % growth | -1.31 29.95% | -1.40 | 0.09 | 6.48% |
| Q1 2020 Q2Q % growth | -0.59 62.89% | -1.70 | 1.11 | 65.27% |
| Q4 2019 Q2Q % growth | -1.60 | -1.76 | 0.16 | 8.88% |
| Q3 2019 Q2Q % growth | -1.81 | -1.83 | 0.02 | 1.30% |
| Q2 2019 Q2Q % growth | -1.87 | -1.73 | -0.14 | -7.86% |
| Q1 2019 Q2Q % growth | -1.59 | -1.79 | 0.20 | 10.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 12.88M 43.69% | 10.625M | 2.255M | 21.22% |
| Q2 2025 Q2Q % growth | 12.455M 44.57% | 9.669M | 2.786M | 28.81% |
| Q1 2025 Q2Q % growth | 8.726M 6.56% | 9.833M | -1.107M | -11.26% |
| Q4 2024 Q2Q % growth | 10.73M 51.06% | 9.513M | 1.217M | 12.79% |
| Q3 2024 Q2Q % growth | 8.964M 21.15% | 9.65M | -686K | -7.11% |
| Q2 2024 Q2Q % growth | 8.615M 28.35% | 9.494M | -879K | -9.26% |
| Q1 2024 Q2Q % growth | 8.189M 46.00% | 8.538M | -349K | -4.09% |
| Q4 2023 Q2Q % growth | 7.103M 64.80% | 8.078M | -975K | -12.07% |
| Q3 2023 Q2Q % growth | 7.399M 110.20% | 7.672M | -273K | -3.56% |
| Q2 2023 Q2Q % growth | 6.712M 20.29% | 6.592M | 120K | 1.82% |
| Q1 2023 Q2Q % growth | 5.609M 575.78% | 5.339M | 270K | 5.06% |
| Q4 2022 Q2Q % growth | 4.31M | 4.623M | -313K | -6.77% |
| Q3 2022 Q2Q % growth | 3.52M | 5.345M | -1.825M | -34.14% |
| Q2 2022 Q2Q % growth | 5.58M | 2.472M | 3.108M | 125.73% |
| Q1 2022 Q2Q % growth | 830K | 2.766M | -1.936M | -69.99% |
| Q4 2021 Q2Q % growth | 569.996K | -569.996K | -100.00% | |
| Q3 2021 Q2Q % growth | 2.648M | -2.648M | -100.00% | |
| Q2 2021 Q2Q % growth | 2.59M | -2.59M | -100.00% | |
| Q1 2021 Q2Q % growth | 45.492M | -45.492M | -100.00% | |
| Q4 2020 Q2Q % growth | 100.00% | 40.975M | -40.975M | -100.00% |
| Q3 2020 Q2Q % growth | -100.00% | 38.783M | -38.783M | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | 38.466M | -38.466M | -100.00% |
| Q1 2020 Q2Q % growth | -100.00% | 31.446M | -31.446M | -100.00% |
| Q4 2019 Q2Q % growth | -82.47M | 34.396M | -116.866M | -339.77% |
| Q3 2019 Q2Q % growth | 26.02M | 33.814M | -7.794M | -23.05% |
| Q2 2019 Q2Q % growth | 26.22M | 27.594M | -1.374M | -4.98% |
| Q1 2019 Q2Q % growth | 30.23M | 23.144M | 7.086M | 30.62% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.13% | 0.98% | 0.15% | -2.29% |
| Revenue | 0.01% | 4.81% | -0.02% | 4.04% |